Types and Characteristics of Antidepressants
Antidepressants work by altering neurotransmitter activity in the brain to improve mood, reduce anxiety, and treat related conditions. The main neurotransmitters involved are serotonin, norepinephrine, and in some cases dopamine.
For nurses, these drugs demand careful monitoring, thorough patient education, and awareness of potentially dangerous interactions. Therapeutic effects are delayed (often 2–6 weeks), which means patients need consistent support during that gap.
Types of Antidepressants
Selective Serotonin Reuptake Inhibitors (SSRIs) are the most commonly prescribed first-line antidepressants. They selectively block the reuptake of serotonin in the synaptic cleft, increasing serotonin availability. Because they're selective for serotonin, they tend to have fewer side effects than older classes.
- Common SSRIs: fluoxetine, sertraline, paroxetine, citalopram, escitalopram
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) block reuptake of both serotonin and norepinephrine. This dual action makes them useful for depression, anxiety disorders, and certain chronic pain conditions like fibromyalgia and neuropathic pain.
- Common SNRIs: venlafaxine, duloxetine, desvenlafaxine
Tricyclic Antidepressants (TCAs) also block serotonin and norepinephrine reuptake, but they additionally block histaminic, muscarinic, and alpha-adrenergic receptors. These extra receptor effects are what cause their broader side effect profile. TCAs are generally not first-line due to these side effects and their danger in overdose.
- Common TCAs: amitriptyline, nortriptyline, imipramine, desipramine
Monoamine Oxidase Inhibitors (MAOIs) inhibit the enzyme monoamine oxidase, which normally breaks down serotonin, norepinephrine, and dopamine. Blocking this enzyme raises levels of all three neurotransmitters. MAOIs are typically reserved for treatment-resistant depression because they require strict dietary restrictions (avoiding tyramine-rich foods) and carry a high risk of serious drug interactions.
- Common MAOIs: phenelzine, tranylcypromine, isocarboxazid
Atypical Antidepressants don't fit neatly into the other categories. Each has a distinct mechanism:
- Bupropion inhibits dopamine and norepinephrine reuptake (notably does not affect serotonin, so it has a lower risk of sexual dysfunction and is also used for smoking cessation)
- Trazodone acts as a serotonin antagonist and reuptake inhibitor; frequently used at low doses for insomnia
- Mirtazapine blocks certain serotonin and histamine receptors, which can cause sedation and appetite stimulation
- Other atypicals include vilazodone and vortioxetine
Mechanisms, Indications, and Side Effects
How Antidepressants Work
The core idea across most antidepressant classes is the same: increase the availability of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) in the synaptic cleft. The classes differ in which neurotransmitters they target and how they increase availability.
- SSRIs, SNRIs, and TCAs block reuptake transporters, preventing neurotransmitters from being pulled back into the presynaptic neuron.
- MAOIs block the enzyme that breaks down neurotransmitters inside the neuron, so more is available for release.
- Atypicals use varied mechanisms (receptor antagonism, reuptake inhibition of different combinations).
The therapeutic window is the drug concentration range that produces the desired effect without excessive adverse effects. TCAs in particular have a narrow therapeutic window, making them dangerous in overdose.
Indications
Antidepressants are used for more than just depression:
- Major depressive disorder (all classes)
- Anxiety disorders: generalized anxiety disorder, panic disorder, social anxiety disorder (SSRIs and SNRIs are first-line)
- Obsessive-compulsive disorder (SSRIs, particularly fluvoxamine, fluoxetine, sertraline)
- Post-traumatic stress disorder (SSRIs such as sertraline and paroxetine are FDA-approved)
- Chronic pain conditions: fibromyalgia, neuropathic pain (duloxetine, TCAs like amitriptyline)
- Insomnia (trazodone at low doses)
- Smoking cessation (bupropion)
Side Effects by Class
| Class | Common Side Effects | Key Concerns |
|---|---|---|
| SSRIs | Nausea, diarrhea, headache, insomnia, sexual dysfunction | Serotonin syndrome (especially with other serotonergic drugs) |
| SNRIs | Similar to SSRIs plus elevated blood pressure (venlafaxine) | Monitor BP; discontinuation syndrome can be significant |
| TCAs | Anticholinergic effects (dry mouth, constipation, urinary retention, blurred vision), sedation, weight gain, orthostatic hypotension | Cardiotoxic in overdose; narrow therapeutic window |
| MAOIs | Insomnia, dizziness, weight gain | Hypertensive crisis with tyramine-rich foods (aged cheeses, cured meats, fermented foods, draft beer) |
| Atypicals | Varies by drug | Bupropion: lowers seizure threshold; Mirtazapine: sedation, weight gain; Trazodone: sedation, priapism (rare but serious) |
Anticholinergic effects are easy to remember: "Can't see, can't pee, can't spit, can't sh*t" (blurred vision, urinary retention, dry mouth, constipation). These are most prominent with TCAs.
Nursing Considerations
Assessment and Monitoring
- Assess mental status at baseline and throughout treatment. Use standardized tools (e.g., PHQ-9) to track mood changes. Always screen for suicidal ideation, especially during the first few weeks of treatment or after dose changes, when energy may improve before mood does.
- Review the medication list for potential interactions. Combining serotonergic drugs (SSRIs + triptans, tramadol, or MAOIs) increases the risk of serotonin syndrome.
- Monitor for serotonin syndrome, which presents with a triad of symptoms: mental status changes (agitation, confusion), autonomic instability (tachycardia, diaphoresis, hyperthermia), and neuromuscular abnormalities (tremor, clonus, hyperreflexia). This is a medical emergency.
- Monitor vital signs as appropriate: blood pressure with SNRIs (especially venlafaxine), orthostatic blood pressure with TCAs, and temperature if serotonin syndrome is suspected.
Administration
- Most antidepressants are given once daily. Some (like trazodone for insomnia) are given at bedtime; activating drugs (like fluoxetine or bupropion) are typically given in the morning.
- Educate patients that full therapeutic effects take 2–6 weeks. During this lag period, patients may feel no improvement or even feel worse, so consistent follow-up is critical.
- Never abruptly discontinue antidepressants (except bupropion, which has a lower risk). Gradual tapering prevents discontinuation syndrome, which can include flu-like symptoms, insomnia, nausea, dizziness, and sensory disturbances (sometimes described as "brain zaps"). Paroxetine and venlafaxine are particularly associated with this.
Collaboration and Safety
- If initial treatment is not effective after an adequate trial (typically 4–8 weeks at therapeutic dose), collaborate with the prescriber about dose adjustment, switching agents, or augmentation strategies (e.g., adding a second medication like an atypical antipsychotic or lithium).
- Advise patients to avoid alcohol and illicit drugs, which can worsen depression and interact with antidepressants.
- For patients on MAOIs, provide a clear list of foods and medications to avoid. A tyramine-restricted diet must be maintained during treatment and for at least 2 weeks after discontinuation (due to the irreversible binding of MAOIs to the enzyme).
- Encourage participation in psychotherapy (such as CBT) and support groups as part of a comprehensive treatment plan. Medication alone is often less effective than medication combined with therapy.
Black Box Warning: All antidepressants carry an FDA black box warning for increased risk of suicidal thinking and behavior in children, adolescents, and young adults (up to age 24), particularly during the first few months of treatment or after dose changes. Close monitoring during this period is essential.
Patient Education
Effective patient education improves adherence and safety. Cover these key points:
About the medication:
- Explain the specific antidepressant prescribed, what it does, and what side effects to watch for.
- Stress that it takes 2–6 weeks for full therapeutic effects. Not feeling better right away doesn't mean the medication isn't working.
- Do not stop the medication abruptly. If they want to stop or are experiencing side effects, they should contact their provider first so the dose can be tapered safely.
Lifestyle support:
- Regular physical activity (even 30 minutes of walking most days) has evidence-based benefits for depression.
- Maintain a consistent sleep schedule and practice good sleep hygiene.
- Eat a balanced diet. For patients on MAOIs, provide written instructions on tyramine-containing foods to avoid.
- Limit or avoid alcohol.
Self-monitoring:
- Encourage keeping a mood diary to track symptoms, side effects, and potential triggers. This gives the healthcare team useful data at follow-up visits.
- Teach patients to recognize worsening symptoms or new suicidal thoughts and to seek help immediately if these occur.
When to seek help:
- Worsening depression or new suicidal thoughts
- Signs of serotonin syndrome (agitation, rapid heart rate, fever, muscle twitching)
- Severe side effects
- Provide crisis resources (e.g., 988 Suicide and Crisis Lifeline)
Follow-up:
- Emphasize the importance of keeping all follow-up appointments, especially early in treatment when monitoring is most critical.
- Encourage open communication with providers about concerns, side effects, or questions about treatment.